FI944822A0 - Galantaminderivat, förfarande för framställning av dessa och användning av dessa i läkemedel - Google Patents

Galantaminderivat, förfarande för framställning av dessa och användning av dessa i läkemedel

Info

Publication number
FI944822A0
FI944822A0 FI944822A FI944822A FI944822A0 FI 944822 A0 FI944822 A0 FI 944822A0 FI 944822 A FI944822 A FI 944822A FI 944822 A FI944822 A FI 944822A FI 944822 A0 FI944822 A0 FI 944822A0
Authority
FI
Finland
Prior art keywords
drugs
preparation
alkylaminocarbonyloxy
galantamine derivatives
alkylaminocarbonyl
Prior art date
Application number
FI944822A
Other languages
English (en)
Finnish (fi)
Other versions
FI944822A (sv
FI108724B (sv
Inventor
Raymond W Kosley Jr
Larry Davis
Veronica Taberna
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of FI944822A0 publication Critical patent/FI944822A0/sv
Publication of FI944822A publication Critical patent/FI944822A/sv
Application granted granted Critical
Publication of FI108724B publication Critical patent/FI108724B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI944822A 1993-10-15 1994-10-13 Förfarande för framställning av terapeutiskt användbara karbamoyloxiderivat av 4a,5,9,10,11,12-hexahydro-11-metyl-6H-bensofuro[3a,3,2-ef][2]bensazepin 3,6-diol och farmaceutiskt godtagbara syraadditionssalter därav FI108724B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13744393 1993-10-15
US08/137,443 US6323196B1 (en) 1993-10-15 1993-10-15 Galanthamine derivatives as acetylcholinesterase inhibitors

Publications (3)

Publication Number Publication Date
FI944822A0 true FI944822A0 (sv) 1994-10-13
FI944822A FI944822A (sv) 1995-04-16
FI108724B FI108724B (sv) 2002-03-15

Family

ID=22477457

Family Applications (1)

Application Number Title Priority Date Filing Date
FI944822A FI108724B (sv) 1993-10-15 1994-10-13 Förfarande för framställning av terapeutiskt användbara karbamoyloxiderivat av 4a,5,9,10,11,12-hexahydro-11-metyl-6H-bensofuro[3a,3,2-ef][2]bensazepin 3,6-diol och farmaceutiskt godtagbara syraadditionssalter därav

Country Status (24)

Country Link
US (1) US6323196B1 (sv)
EP (2) EP1020469A3 (sv)
JP (1) JP2718637B2 (sv)
KR (1) KR100189043B1 (sv)
CN (1) CN1039011C (sv)
AT (1) ATE201687T1 (sv)
AU (1) AU679560B2 (sv)
CA (1) CA2118171C (sv)
CZ (1) CZ283561B6 (sv)
DE (1) DE69427332T2 (sv)
DK (1) DK0648771T3 (sv)
EG (1) EG20747A (sv)
ES (1) ES2158876T3 (sv)
FI (1) FI108724B (sv)
GR (1) GR3036068T3 (sv)
IL (1) IL111273A (sv)
NO (1) NO307463B1 (sv)
NZ (1) NZ264681A (sv)
PL (1) PL177754B1 (sv)
PT (1) PT648771E (sv)
RO (1) RO114132B1 (sv)
RU (1) RU2113438C1 (sv)
TW (1) TW375615B (sv)
ZA (1) ZA948060B (sv)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT403803B (de) 1996-04-19 1998-05-25 Sanochemia Ltd Neue benzazepinderivate, diese enthaltende arzneimittel und verwendung derselben zum herstellen von arzneimitteln
JP5558648B2 (ja) 1998-11-23 2014-07-23 デイビス、ボニー アセチルコリンエステラーゼ阻害剤のための投与製剤
PT1140105E (pt) 1998-12-24 2004-03-31 Janssen Pharmaceutica Nv Composicao de galantamina de libertacao controlada
CA2393301A1 (en) * 1999-12-10 2001-06-21 Bonnie Davis Analogs of galanthamine and lycoramine as modulators of nicotinic receptors
EP1181294B1 (de) 2000-03-31 2004-03-31 Sanochemia Pharmazeutika Aktiengesellschaft Neue derivate und analoga von galanthamin
US20030162770A1 (en) * 2002-02-22 2003-08-28 Davis Bonnie M. Use of modulators of nicotinic receptors for treatment of cognitive dysfunction
AU2003287433A1 (en) * 2002-11-01 2004-06-07 Oregon Health And Science University Treatment of hyperkinetic movement disorder with donepezil
US20050048543A1 (en) * 2003-07-11 2005-03-03 Jeroen Aerssens CHRNA2 genetic markers associated with galantamine response
US20050260613A1 (en) * 2003-10-28 2005-11-24 Genaissance Pharmaceuticals LRPAP1 genetic markers associated with galantamine
US20050143350A1 (en) * 2003-11-19 2005-06-30 Seed John C. Combination drug therapy to treat obesity
US7250258B2 (en) * 2003-12-15 2007-07-31 Pgxhealth Llc CDK5 genetic markers associated with galantamine response
WO2005065662A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Solid dosage formulations of galantamine
WO2005065661A2 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Immediate, controlled and sustained release formulations of galanthamine
WO2006004201A1 (ja) * 2004-07-01 2006-01-12 Eisai R & D Management Co., Ltd. 神経再生促進剤
EP2316437B1 (en) * 2005-05-13 2014-07-30 Alza Corporation Multilayer drug delivery system with barrier against reservoir material flow
US20080188510A1 (en) * 2005-05-23 2008-08-07 Eisai R & D Management Co., Ltd. Novel methods using zonisamide
EP1777222A1 (en) * 2005-09-22 2007-04-25 Galantos Pharma GmbH Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment
US20090253654A1 (en) 2005-09-22 2009-10-08 Galantos Pharma Gmbh Cholinergic enhancers with improved blood-brain barrier permeability for the treatment of diseases accompanied by cognitive impairment
WO2007035941A2 (en) * 2005-09-23 2007-03-29 Alza Corporation Transdermal galantamine delivery system
KR100786371B1 (ko) * 2006-12-07 2007-12-17 한국화학연구원 갈란타민의 제조방법
ES2463715T3 (es) 2008-04-14 2014-05-29 Neurodyn Life Sciences Inc. Derivados de galantamina como profármacos para el tratamiento de enfermedades del cerebro humano
MX2012000939A (es) * 2009-07-23 2012-06-08 Shire Llc Profarmacos de peptidos y aminoacidos de galantamina y usos de los mismos.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL122665B1 (en) 1978-11-21 1982-08-31 Edinen Zentar Chim Process for preparing novel dienones of narvedine type and their derivatives
US4663318A (en) 1986-01-15 1987-05-05 Bonnie Davis Method of treating Alzheimer's disease
US6150354A (en) * 1987-01-15 2000-11-21 Bonnie Davis Compounds for the treatment of Alzheimer's disease
AU632458B2 (en) * 1987-05-04 1993-01-07 Bonnie Davis Compounds for the treatment of alzheimer's disease
NL8800350A (nl) 1988-02-12 1989-09-01 Stichting Biomedical Research Synthetische galanthamine-derivaten, werkwijze voor het bereiden daarvan, en farmaceutische samenstellingen.
US5336675A (en) * 1991-05-14 1994-08-09 Ernir Snorrason Method of treating mania in humans
DK0584185T3 (da) * 1991-05-14 2000-02-07 Ernir Snorrason Behandling af træthedssyndrom med cholinesteraseinhibitorer
US5231093A (en) * 1991-10-01 1993-07-27 Hoechst-Roussel Pharmaceuticals Incorporated Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs
US5153193A (en) 1991-10-01 1992-10-06 Hoechst-Roussel Pharmaceuticals Incorporated Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs

Also Published As

Publication number Publication date
NO307463B1 (no) 2000-04-10
TW375615B (en) 1999-12-01
CN1108658A (zh) 1995-09-20
EP0648771B1 (en) 2001-05-30
ATE201687T1 (de) 2001-06-15
RU94036761A (ru) 1996-09-10
NO943894L (no) 1995-04-18
FI944822A (sv) 1995-04-16
IL111273A0 (en) 1994-12-29
CZ254794A3 (en) 1995-05-17
AU679560B2 (en) 1997-07-03
DE69427332T2 (de) 2001-10-11
US6323196B1 (en) 2001-11-27
CA2118171C (en) 1999-12-28
GR3036068T3 (en) 2001-09-28
RO114132B1 (ro) 1999-01-29
KR100189043B1 (ko) 1999-06-01
KR950011444A (ko) 1995-05-15
PT648771E (pt) 2001-09-28
FI108724B (sv) 2002-03-15
IL111273A (en) 1998-04-05
DE69427332D1 (de) 2001-07-05
RU2113438C1 (ru) 1998-06-20
NO943894D0 (no) 1994-10-14
JP2718637B2 (ja) 1998-02-25
EP1020469A2 (en) 2000-07-19
EG20747A (en) 2000-01-31
ES2158876T3 (es) 2001-09-16
DK0648771T3 (da) 2001-08-27
PL305455A1 (en) 1995-04-18
CA2118171A1 (en) 1995-04-16
PL177754B1 (pl) 2000-01-31
EP1020469A3 (en) 2000-07-26
CZ283561B6 (cs) 1998-05-13
ZA948060B (en) 1995-06-09
JPH07188238A (ja) 1995-07-25
EP0648771A1 (en) 1995-04-19
AU7581294A (en) 1995-05-04
CN1039011C (zh) 1998-07-08
NZ264681A (en) 1997-12-19

Similar Documents

Publication Publication Date Title
FI944822A0 (sv) Galantaminderivat, förfarande för framställning av dessa och användning av dessa i läkemedel
LU91210I2 (fr) Emodepside & Praziquantel ainsi que leurs dérivés pharmaceutiqement acceptables (PROFENDER)
AU1433588A (en) 1-phenyl-3-naphthalenyloxypropanamines
FI944821A0 (sv) Galantaminderivat, förfarande för framställning av dessa och användning av dessa i läkemedel
IE880960L (en) Organic salts of physostigmine derivatives
HU904956D0 (en) Process for producing benzopyrane derivatives and pharmaceutical preparatives containing such active agents
DE69505470D1 (de) Pyrrolocarbazol
AU3797189A (en) Piperidine derivatives
ES2150613T3 (es) Compuestos benzo-condensados de acepinona y piperidinona, utiles como inhibidores de ace y nep.
GB8706662D0 (en) Anti-arrhythmia agents
MX9206930A (es) Nuevos compuestos
EP0555479A4 (sv)
DE69001004D1 (de) Zusammensetzung gegen leberkrankheiten.
DK540589A (da) Pyrrolidinderivater
DK0998464T3 (da) Polyhydroxyalkylpyrazinderivater, deres fremstilling samt medikamenter indeholdende disse forbindelser
GR3030952T3 (en) Salmycins, a process for their preparation and their use as a pharmaceutical.
HK34095A (en) Use of 2-oxo-imidazolidine derivatives in the treatment of kidney diseases
ES8300709A1 (es) Un metodo para la preparacion de derivados de pirazolidinona

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: HOECHST MARION ROUSSEL, INC.

PC Transfer of assignment of patent

Owner name: AVENTISUB II INC.

Free format text: AVENTISUB II INC.

MA Patent expired